Initial findings of impact of strut width on stent coverage and apposition of sirolimus-eluting stents assessed by optical coherence tomography

Catheterization and Cardiovascular Interventions

Volumn 81, Issue 5, 2013, Pages 776-781

  Nakatani, Shimpei ^a   Nishino, Masami ^a   Taniike, Masayuki ^a   Makino, Nobuhiko ^a   Kato, Hiroyasu ^a   Egami, Yasuyuki ^a   Shutta, Ryu ^a   Tanouchi, Jun ^a   Yamada, Yoshio ^a  

^a OSAKA ROSAI HOSPITAL   (Japan)

Author keywords

Coronary artery disease; Optical coherence tomography; Stent coverage; Stents

Indexed keywords

RAPAMYCIN; CARDIOVASCULAR AGENT;

ADULT; ARTICLE; BARE METAL STENT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ELUTING STENT; EQUIPMENT DESIGN; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPERPLASIA; IMPLANTATION; INCIDENCE; MALE; OPTICAL COHERENCE TOMOGRAPHY; SIROLIMUS ELUTING STENT; STENT IMPLANTATION; STENT MALAPPOSITION; STENT THROMBOSIS; AGED; CHI SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; CORONARY BLOOD VESSEL; DRUG EFFECT; EQUIPMENT; MIDDLE AGED; NEOINTIMA; PATHOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PROSTHESIS; TIME; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; CORONARY THROMBOSIS; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOINTIMA; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; PROSTHESIS DESIGN; SIROLIMUS; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME;

EID: 84884182154     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24401     Document Type: Article

References (21)

1. Farb A, Burke AP, Kolodgie FD, Virmani R. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 2003;108:1701-1706.
2. Alfonso F, Suarez A, Perez-Vizcayno MJ, Moreno R, Escaned J, et al. Intravascular ultrasound findings during episodes ofdrug-eluting stent thrombosis. J Am Coll Cardiol 2007;50: 2095-2097.
3. Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C, Vogel R, Hess O, Meier B, Windecker S. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 2007;115:2426-2434.
4. Miyazawa A, Ako J, Hongo Y, Hur SH, Tsujino I, Courtney BK, Hassan AH, Kandzari DE, Honda Y, Fitzgerald PJ. Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: Intravascular ultrasound results from ENDEAVOR III. Am Heart J 2008;155:108-113.
5. Nakazawa G, Finn AV, John MC, Kolodgie FD, Virmani R. The significance of preclinical evaluation of sirolimus-, paclitaxel-, and zotarolimus-eluting stents. Am J Cardiol 2007;100:36M-44M.
6. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R. Pathology of drugeluting stents in humans: Delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202.
7. Ishigami K, Uemura S, Morikawa Y, Soeda T, Okayama S, et al. Long-term follow-up of neointimal coverage of sirolimuseluting stents - Evaluation with optical coherence tomography. Circ J 2009;73:2300-2307.
8. Balakrishnan B, Tzafriri AR, Seifert P, Groothuis A, Rogers C, Edelman ER. Strut position, blood flow, and drug deposition: Implications for single and overlapping drug-eluting stents. Circulation 2005;111:2958-2965.
9. Chen BX, Ma FY, Luo W, Ruan JH, Xie WL, Zhao XZ, Sun SH, Guo XM, Wang F, Tian T, Chu XW. Neointimal coverage of bare-metal and sirolimus-eluting stents evaluated with optical coherence tomography. Heart 2008;94:566-570.
10. Kim JS, Jang IK, Kim TH, Kim JS, Kim TH, Takano M, Kume T, Hur NW, Ko YG, Choi D, Hong MK, Jang Y. Optical coherence tomography evaluation of zotarolimus-eluting stents at 9- month follow-up: comparison with sirolimus-eluting stents. Heart 2009;95:1907-1912.
11. Kim JS, Kim JS, Kim TH, Fan C, Lee JM, Kim W, Ko YG, Choi D, Hong MK, Jang Y. Comparison of neointimal coverage of sirolimus-eluting stents and paclitaxel-eluting stents using optical coherence tomography at 9 months after implantation. Circ J 2010;74:320-326.
12. Mehanna EA, Attizzani GF, Kyono H, Hake M, Bezerra HG. Assessment of coronary stent by optical coherence tomography, methodology and definitions. Int J Cardiovasc Imaging 2011;27:259-269.
13. Rittersma SZ, de Winter RJ, Koch KT, Bax M, Schotborgh CE, Mulder KJ, Tijssen JG, Piek JJ. Impact of strut thickness on late luminal loss after coronary artery stent placement. Am J Cardiol 2004;93:477-480.
14. Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, Virmani R. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol 2007;27:1500-1510.
15. Tanigawa J, Barlis P, Dimopoulos K, Dalby M, Moore P, Di Mario C. The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography. Int J Cardiol 2009;134:180-188.
16. Lansky AJ, Roubin GS, O'Shaughnessy CD, Moore PB, Dean LS, et al. Randomized comparison of GR-II stent and Palmaz- Schatz stent for elective treatment of coronary stenoses. Circulation 2000;102:1364-1368.
17. Simon C, Palmaz JC, Sprague EA. Influence of topography on endothelialization of stents: Clues for new designs. J Long Term Eff Med Implants 2000;10:143-151.
18. Kastrati A, Mehilli J, Dirschinger J, Pache J, Ulm K, et al. Restenosis after coronary placement of various stent types. Am J Cardiol 2001;87:34-39.
19. Kastrati A, Mehilli J, Dirschinger J, Dotzer F, Schuhlen H, Neumann FJ, Fleckenstein M, Pfafferott C, Seyfarth M, Schomig A. Intracoronary stenting and angiographic results: Strut thickness effect on restenosis outcome (ISAR-STEREO) trial. Circulation 2001;103:2816-2821.
20. Pache J, Kastrati A, Mehilli J, Schuhlen H, Dotzer F, et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. J Am Coll Cardiol 2003;41:1283-1288.
21. Hausleiter J, Kastrati A, Mehilli J, Schuhlen H, Pache J, Dotzer F, Sattelberger U, Dirschinger J, Schomig A. Impact of lesion complexity on the capacity of a trial to detect differences in stent performance: Results from the ISAR-STEREO trial. Am Heart J 2003;146:882-886.